nodes	percent_of_prediction	percent_of_DWPC	metapath
Diltiazem—CYP2C8—Vismodegib—skin cancer	0.0944	0.127	CbGbCtD
Diltiazem—CYP2C19—Vismodegib—skin cancer	0.0792	0.106	CbGbCtD
Diltiazem—CYP2C9—Vismodegib—skin cancer	0.0658	0.0883	CbGbCtD
Diltiazem—ABCB1—Vismodegib—skin cancer	0.0639	0.0857	CbGbCtD
Diltiazem—CYP3A4—Imiquimod—skin cancer	0.0552	0.0741	CbGbCtD
Diltiazem—CYP3A4—Temozolomide—skin cancer	0.0552	0.0741	CbGbCtD
Diltiazem—CYP2D6—Vemurafenib—skin cancer	0.0476	0.0638	CbGbCtD
Diltiazem—CYP3A4—Vismodegib—skin cancer	0.0383	0.0513	CbGbCtD
Diltiazem—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0355	0.0476	CbGbCtD
Diltiazem—CYP3A7—Docetaxel—skin cancer	0.0355	0.0476	CbGbCtD
Diltiazem—ABCB1—Dactinomycin—skin cancer	0.0336	0.045	CbGbCtD
Diltiazem—CYP2C8—Fluorouracil—skin cancer	0.0335	0.045	CbGbCtD
Diltiazem—CYP3A4—Vemurafenib—skin cancer	0.0303	0.0406	CbGbCtD
Diltiazem—CYP3A5—Docetaxel—skin cancer	0.0266	0.0357	CbGbCtD
Diltiazem—CYP2C9—Fluorouracil—skin cancer	0.0234	0.0314	CbGbCtD
Diltiazem—ABCB1—Docetaxel—skin cancer	0.0173	0.0232	CbGbCtD
Diltiazem—CACNA1S—pes—skin cancer	0.0158	0.762	CbGeAlD
Diltiazem—CYP3A4—Docetaxel—skin cancer	0.0104	0.0139	CbGbCtD
Diltiazem—CACNA1C—connective tissue—skin cancer	0.000851	0.0412	CbGeAlD
Diltiazem—CACNA1C—female reproductive system—skin cancer	0.0006	0.029	CbGeAlD
Diltiazem—CACNA1C—head—skin cancer	0.000502	0.0243	CbGeAlD
Diltiazem—ABCB1—blood vessel—skin cancer	0.000434	0.021	CbGeAlD
Diltiazem—Urinary tract disorder—Temozolomide—skin cancer	0.000393	0.00168	CcSEcCtD
Diltiazem—Oedema peripheral—Temozolomide—skin cancer	0.000392	0.00168	CcSEcCtD
Diltiazem—Pruritus—Vemurafenib—skin cancer	0.000392	0.00168	CcSEcCtD
Diltiazem—Lethargy—Docetaxel—skin cancer	0.000391	0.00167	CcSEcCtD
Diltiazem—Urethral disorder—Temozolomide—skin cancer	0.00039	0.00167	CcSEcCtD
Diltiazem—Alopecia—Dactinomycin—skin cancer	0.000389	0.00167	CcSEcCtD
Diltiazem—Feeling abnormal—Imiquimod—skin cancer	0.000389	0.00166	CcSEcCtD
Diltiazem—Epistaxis—Fluorouracil—skin cancer	0.000386	0.00165	CcSEcCtD
Diltiazem—Visual impairment—Temozolomide—skin cancer	0.000384	0.00164	CcSEcCtD
Diltiazem—Sinusitis—Fluorouracil—skin cancer	0.000383	0.00164	CcSEcCtD
Diltiazem—Erythema—Dactinomycin—skin cancer	0.000383	0.00164	CcSEcCtD
Diltiazem—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000383	0.00164	CcSEcCtD
Diltiazem—Agranulocytosis—Fluorouracil—skin cancer	0.000381	0.00163	CcSEcCtD
Diltiazem—Ill-defined disorder—Bleomycin—skin cancer	0.000381	0.00163	CcSEcCtD
Diltiazem—Diarrhoea—Vemurafenib—skin cancer	0.000379	0.00162	CcSEcCtD
Diltiazem—Erythema multiforme—Temozolomide—skin cancer	0.000377	0.00161	CcSEcCtD
Diltiazem—Urticaria—Imiquimod—skin cancer	0.000375	0.00161	CcSEcCtD
Diltiazem—Body temperature increased—Imiquimod—skin cancer	0.000373	0.0016	CcSEcCtD
Diltiazem—Abdominal pain—Imiquimod—skin cancer	0.000373	0.0016	CcSEcCtD
Diltiazem—Eye disorder—Temozolomide—skin cancer	0.000372	0.00159	CcSEcCtD
Diltiazem—Tinnitus—Temozolomide—skin cancer	0.000371	0.00159	CcSEcCtD
Diltiazem—Malaise—Bleomycin—skin cancer	0.000371	0.00159	CcSEcCtD
Diltiazem—Flushing—Temozolomide—skin cancer	0.00037	0.00158	CcSEcCtD
Diltiazem—Cardiac disorder—Temozolomide—skin cancer	0.00037	0.00158	CcSEcCtD
Diltiazem—Leukopenia—Bleomycin—skin cancer	0.000368	0.00157	CcSEcCtD
Diltiazem—Rhinitis—Fluorouracil—skin cancer	0.000368	0.00157	CcSEcCtD
Diltiazem—Dizziness—Vemurafenib—skin cancer	0.000366	0.00157	CcSEcCtD
Diltiazem—Pharyngitis—Fluorouracil—skin cancer	0.000364	0.00156	CcSEcCtD
Diltiazem—Angiopathy—Temozolomide—skin cancer	0.000361	0.00155	CcSEcCtD
Diltiazem—Mediastinal disorder—Temozolomide—skin cancer	0.000359	0.00154	CcSEcCtD
Diltiazem—Cough—Bleomycin—skin cancer	0.000359	0.00153	CcSEcCtD
Diltiazem—Ill-defined disorder—Dactinomycin—skin cancer	0.000356	0.00152	CcSEcCtD
Diltiazem—Vomiting—Vemurafenib—skin cancer	0.000352	0.00151	CcSEcCtD
Diltiazem—Alopecia—Temozolomide—skin cancer	0.000352	0.00151	CcSEcCtD
Diltiazem—CACNA1C—lymph node—skin cancer	0.000351	0.017	CbGeAlD
Diltiazem—Chest pain—Bleomycin—skin cancer	0.00035	0.0015	CcSEcCtD
Diltiazem—Myalgia—Bleomycin—skin cancer	0.00035	0.0015	CcSEcCtD
Diltiazem—Orthostatic hypotension—Docetaxel—skin cancer	0.00035	0.0015	CcSEcCtD
Diltiazem—Abdominal pain upper—Docetaxel—skin cancer	0.00035	0.0015	CcSEcCtD
Diltiazem—Rash—Vemurafenib—skin cancer	0.000349	0.00149	CcSEcCtD
Diltiazem—Dermatitis—Vemurafenib—skin cancer	0.000349	0.00149	CcSEcCtD
Diltiazem—Hypersensitivity—Imiquimod—skin cancer	0.000348	0.00149	CcSEcCtD
Diltiazem—Headache—Vemurafenib—skin cancer	0.000347	0.00148	CcSEcCtD
Diltiazem—Erythema—Temozolomide—skin cancer	0.000347	0.00148	CcSEcCtD
Diltiazem—Malnutrition—Temozolomide—skin cancer	0.000347	0.00148	CcSEcCtD
Diltiazem—Discomfort—Bleomycin—skin cancer	0.000346	0.00148	CcSEcCtD
Diltiazem—Malaise—Dactinomycin—skin cancer	0.000346	0.00148	CcSEcCtD
Diltiazem—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000345	0.00148	CcSEcCtD
Diltiazem—Cramp muscle—Docetaxel—skin cancer	0.000345	0.00148	CcSEcCtD
Diltiazem—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000345	0.00148	CcSEcCtD
Diltiazem—Leukopenia—Dactinomycin—skin cancer	0.000343	0.00147	CcSEcCtD
Diltiazem—Nasopharyngitis—Docetaxel—skin cancer	0.000342	0.00146	CcSEcCtD
Diltiazem—Dysgeusia—Temozolomide—skin cancer	0.000339	0.00145	CcSEcCtD
Diltiazem—Asthenia—Imiquimod—skin cancer	0.000339	0.00145	CcSEcCtD
Diltiazem—Oedema—Bleomycin—skin cancer	0.000335	0.00144	CcSEcCtD
Diltiazem—Pruritus—Imiquimod—skin cancer	0.000334	0.00143	CcSEcCtD
Diltiazem—Infection—Bleomycin—skin cancer	0.000333	0.00143	CcSEcCtD
Diltiazem—Nausea—Vemurafenib—skin cancer	0.000329	0.00141	CcSEcCtD
Diltiazem—Thrombocytopenia—Bleomycin—skin cancer	0.000328	0.00141	CcSEcCtD
Diltiazem—Arrhythmia—Fluorouracil—skin cancer	0.000328	0.0014	CcSEcCtD
Diltiazem—CYP2C8—female reproductive system—skin cancer	0.000327	0.0158	CbGeAlD
Diltiazem—Vision blurred—Temozolomide—skin cancer	0.000327	0.0014	CcSEcCtD
Diltiazem—Myalgia—Dactinomycin—skin cancer	0.000326	0.0014	CcSEcCtD
Diltiazem—Tremor—Temozolomide—skin cancer	0.000325	0.00139	CcSEcCtD
Diltiazem—Alopecia—Fluorouracil—skin cancer	0.000324	0.00139	CcSEcCtD
Diltiazem—Diarrhoea—Imiquimod—skin cancer	0.000323	0.00138	CcSEcCtD
Diltiazem—Discomfort—Dactinomycin—skin cancer	0.000322	0.00138	CcSEcCtD
Diltiazem—Ill-defined disorder—Temozolomide—skin cancer	0.000322	0.00138	CcSEcCtD
Diltiazem—Anorexia—Bleomycin—skin cancer	0.00032	0.00137	CcSEcCtD
Diltiazem—Erythema—Fluorouracil—skin cancer	0.000319	0.00137	CcSEcCtD
Diltiazem—Angioedema—Temozolomide—skin cancer	0.000317	0.00136	CcSEcCtD
Diltiazem—Hypotension—Bleomycin—skin cancer	0.000313	0.00134	CcSEcCtD
Diltiazem—Oedema—Dactinomycin—skin cancer	0.000313	0.00134	CcSEcCtD
Diltiazem—Malaise—Temozolomide—skin cancer	0.000313	0.00134	CcSEcCtD
Diltiazem—Dizziness—Imiquimod—skin cancer	0.000312	0.00134	CcSEcCtD
Diltiazem—Vertigo—Temozolomide—skin cancer	0.000311	0.00133	CcSEcCtD
Diltiazem—Infection—Dactinomycin—skin cancer	0.000311	0.00133	CcSEcCtD
Diltiazem—Leukopenia—Temozolomide—skin cancer	0.00031	0.00133	CcSEcCtD
Diltiazem—Palpitations—Temozolomide—skin cancer	0.000306	0.00131	CcSEcCtD
Diltiazem—Thrombocytopenia—Dactinomycin—skin cancer	0.000306	0.00131	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000306	0.00131	CcSEcCtD
Diltiazem—Cough—Temozolomide—skin cancer	0.000303	0.00129	CcSEcCtD
Diltiazem—Paraesthesia—Bleomycin—skin cancer	0.000301	0.00129	CcSEcCtD
Diltiazem—Weight increased—Docetaxel—skin cancer	0.000301	0.00129	CcSEcCtD
Diltiazem—Vision blurred—Fluorouracil—skin cancer	0.000301	0.00129	CcSEcCtD
Diltiazem—Vomiting—Imiquimod—skin cancer	0.0003	0.00128	CcSEcCtD
Diltiazem—Dyspnoea—Bleomycin—skin cancer	0.000299	0.00128	CcSEcCtD
Diltiazem—Anorexia—Dactinomycin—skin cancer	0.000298	0.00128	CcSEcCtD
Diltiazem—Rash—Imiquimod—skin cancer	0.000298	0.00127	CcSEcCtD
Diltiazem—Dermatitis—Imiquimod—skin cancer	0.000297	0.00127	CcSEcCtD
Diltiazem—Headache—Imiquimod—skin cancer	0.000296	0.00127	CcSEcCtD
Diltiazem—Myalgia—Temozolomide—skin cancer	0.000295	0.00126	CcSEcCtD
Diltiazem—Arthralgia—Temozolomide—skin cancer	0.000295	0.00126	CcSEcCtD
Diltiazem—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000292	0.00125	CcSEcCtD
Diltiazem—Discomfort—Temozolomide—skin cancer	0.000292	0.00125	CcSEcCtD
Diltiazem—Decreased appetite—Bleomycin—skin cancer	0.000292	0.00125	CcSEcCtD
Diltiazem—Acute coronary syndrome—Docetaxel—skin cancer	0.000291	0.00124	CcSEcCtD
Diltiazem—CYP2C9—female reproductive system—skin cancer	0.000291	0.0141	CbGeAlD
Diltiazem—Renal failure—Docetaxel—skin cancer	0.00029	0.00124	CcSEcCtD
Diltiazem—Myocardial infarction—Docetaxel—skin cancer	0.000289	0.00124	CcSEcCtD
Diltiazem—Neuropathy peripheral—Docetaxel—skin cancer	0.000289	0.00124	CcSEcCtD
Diltiazem—Dry mouth—Temozolomide—skin cancer	0.000289	0.00124	CcSEcCtD
Diltiazem—Pain—Bleomycin—skin cancer	0.000287	0.00123	CcSEcCtD
Diltiazem—Conjunctivitis—Docetaxel—skin cancer	0.000287	0.00123	CcSEcCtD
Diltiazem—Leukopenia—Fluorouracil—skin cancer	0.000286	0.00122	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000285	0.00122	CcSEcCtD
Diltiazem—Oedema—Temozolomide—skin cancer	0.000283	0.00121	CcSEcCtD
Diltiazem—Infection—Temozolomide—skin cancer	0.000281	0.0012	CcSEcCtD
Diltiazem—Nausea—Imiquimod—skin cancer	0.00028	0.0012	CcSEcCtD
Diltiazem—Epistaxis—Docetaxel—skin cancer	0.000278	0.00119	CcSEcCtD
Diltiazem—Nervous system disorder—Temozolomide—skin cancer	0.000277	0.00119	CcSEcCtD
Diltiazem—Thrombocytopenia—Temozolomide—skin cancer	0.000277	0.00119	CcSEcCtD
Diltiazem—Feeling abnormal—Bleomycin—skin cancer	0.000276	0.00118	CcSEcCtD
Diltiazem—Agranulocytosis—Docetaxel—skin cancer	0.000275	0.00118	CcSEcCtD
Diltiazem—Hyperhidrosis—Temozolomide—skin cancer	0.000274	0.00117	CcSEcCtD
Diltiazem—Chest pain—Fluorouracil—skin cancer	0.000272	0.00116	CcSEcCtD
Diltiazem—Myalgia—Fluorouracil—skin cancer	0.000272	0.00116	CcSEcCtD
Diltiazem—Decreased appetite—Dactinomycin—skin cancer	0.000272	0.00116	CcSEcCtD
Diltiazem—Fatigue—Dactinomycin—skin cancer	0.00027	0.00115	CcSEcCtD
Diltiazem—Anorexia—Temozolomide—skin cancer	0.00027	0.00115	CcSEcCtD
Diltiazem—Discomfort—Fluorouracil—skin cancer	0.000269	0.00115	CcSEcCtD
Diltiazem—Pain—Dactinomycin—skin cancer	0.000267	0.00114	CcSEcCtD
Diltiazem—Urticaria—Bleomycin—skin cancer	0.000266	0.00114	CcSEcCtD
Diltiazem—Rhinitis—Docetaxel—skin cancer	0.000265	0.00114	CcSEcCtD
Diltiazem—Body temperature increased—Bleomycin—skin cancer	0.000265	0.00113	CcSEcCtD
Diltiazem—Hepatitis—Docetaxel—skin cancer	0.000265	0.00113	CcSEcCtD
Diltiazem—Pharyngitis—Docetaxel—skin cancer	0.000263	0.00112	CcSEcCtD
Diltiazem—Urinary tract disorder—Docetaxel—skin cancer	0.000262	0.00112	CcSEcCtD
Diltiazem—Oedema peripheral—Docetaxel—skin cancer	0.000261	0.00112	CcSEcCtD
Diltiazem—Oedema—Fluorouracil—skin cancer	0.000261	0.00112	CcSEcCtD
Diltiazem—Urethral disorder—Docetaxel—skin cancer	0.00026	0.00111	CcSEcCtD
Diltiazem—Infection—Fluorouracil—skin cancer	0.000259	0.00111	CcSEcCtD
Diltiazem—Feeling abnormal—Dactinomycin—skin cancer	0.000258	0.0011	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000258	0.0011	CcSEcCtD
Diltiazem—Insomnia—Temozolomide—skin cancer	0.000256	0.0011	CcSEcCtD
Diltiazem—Nervous system disorder—Fluorouracil—skin cancer	0.000256	0.00109	CcSEcCtD
Diltiazem—Thrombocytopenia—Fluorouracil—skin cancer	0.000255	0.00109	CcSEcCtD
Diltiazem—Visual impairment—Docetaxel—skin cancer	0.000255	0.00109	CcSEcCtD
Diltiazem—Tachycardia—Fluorouracil—skin cancer	0.000254	0.00109	CcSEcCtD
Diltiazem—Paraesthesia—Temozolomide—skin cancer	0.000254	0.00109	CcSEcCtD
Diltiazem—Dyspnoea—Temozolomide—skin cancer	0.000252	0.00108	CcSEcCtD
Diltiazem—Somnolence—Temozolomide—skin cancer	0.000252	0.00108	CcSEcCtD
Diltiazem—Erythema multiforme—Docetaxel—skin cancer	0.00025	0.00107	CcSEcCtD
Diltiazem—Dyspepsia—Temozolomide—skin cancer	0.000249	0.00107	CcSEcCtD
Diltiazem—Anorexia—Fluorouracil—skin cancer	0.000248	0.00106	CcSEcCtD
Diltiazem—Eye disorder—Docetaxel—skin cancer	0.000247	0.00106	CcSEcCtD
Diltiazem—Body temperature increased—Dactinomycin—skin cancer	0.000247	0.00106	CcSEcCtD
Diltiazem—Abdominal pain—Dactinomycin—skin cancer	0.000247	0.00106	CcSEcCtD
Diltiazem—Hypersensitivity—Bleomycin—skin cancer	0.000247	0.00106	CcSEcCtD
Diltiazem—Decreased appetite—Temozolomide—skin cancer	0.000246	0.00105	CcSEcCtD
Diltiazem—Flushing—Docetaxel—skin cancer	0.000246	0.00105	CcSEcCtD
Diltiazem—Cardiac disorder—Docetaxel—skin cancer	0.000246	0.00105	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Temozolomide—skin cancer	0.000244	0.00105	CcSEcCtD
Diltiazem—Fatigue—Temozolomide—skin cancer	0.000244	0.00104	CcSEcCtD
Diltiazem—Hypotension—Fluorouracil—skin cancer	0.000244	0.00104	CcSEcCtD
Diltiazem—Pain—Temozolomide—skin cancer	0.000242	0.00104	CcSEcCtD
Diltiazem—Constipation—Temozolomide—skin cancer	0.000242	0.00104	CcSEcCtD
Diltiazem—Asthenia—Bleomycin—skin cancer	0.000241	0.00103	CcSEcCtD
Diltiazem—Angiopathy—Docetaxel—skin cancer	0.00024	0.00103	CcSEcCtD
Diltiazem—Mediastinal disorder—Docetaxel—skin cancer	0.000239	0.00102	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000237	0.00102	CcSEcCtD
Diltiazem—Pruritus—Bleomycin—skin cancer	0.000237	0.00102	CcSEcCtD
Diltiazem—Arrhythmia—Docetaxel—skin cancer	0.000237	0.00101	CcSEcCtD
Diltiazem—Insomnia—Fluorouracil—skin cancer	0.000236	0.00101	CcSEcCtD
Diltiazem—Paraesthesia—Fluorouracil—skin cancer	0.000234	0.001	CcSEcCtD
Diltiazem—Alopecia—Docetaxel—skin cancer	0.000234	0.001	CcSEcCtD
Diltiazem—Feeling abnormal—Temozolomide—skin cancer	0.000233	0.000998	CcSEcCtD
Diltiazem—Dyspnoea—Fluorouracil—skin cancer	0.000232	0.000995	CcSEcCtD
Diltiazem—Somnolence—Fluorouracil—skin cancer	0.000232	0.000992	CcSEcCtD
Diltiazem—Malnutrition—Docetaxel—skin cancer	0.000231	0.000987	CcSEcCtD
Diltiazem—Erythema—Docetaxel—skin cancer	0.000231	0.000987	CcSEcCtD
Diltiazem—Hypersensitivity—Dactinomycin—skin cancer	0.00023	0.000986	CcSEcCtD
Diltiazem—Dyspepsia—Fluorouracil—skin cancer	0.000229	0.000982	CcSEcCtD
Diltiazem—Decreased appetite—Fluorouracil—skin cancer	0.000227	0.00097	CcSEcCtD
Diltiazem—Dysgeusia—Docetaxel—skin cancer	0.000226	0.000966	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000225	0.000963	CcSEcCtD
Diltiazem—Urticaria—Temozolomide—skin cancer	0.000225	0.000962	CcSEcCtD
Diltiazem—Asthenia—Dactinomycin—skin cancer	0.000224	0.00096	CcSEcCtD
Diltiazem—Abdominal pain—Temozolomide—skin cancer	0.000224	0.000957	CcSEcCtD
Diltiazem—Body temperature increased—Temozolomide—skin cancer	0.000224	0.000957	CcSEcCtD
Diltiazem—Pain—Fluorouracil—skin cancer	0.000223	0.000954	CcSEcCtD
Diltiazem—CYP3A4—female reproductive system—skin cancer	0.000222	0.0107	CbGeAlD
Diltiazem—Muscle spasms—Docetaxel—skin cancer	0.000222	0.000949	CcSEcCtD
Diltiazem—CYP2D6—female reproductive system—skin cancer	0.000218	0.0106	CbGeAlD
Diltiazem—Feeling abnormal—Fluorouracil—skin cancer	0.000215	0.000919	CcSEcCtD
Diltiazem—Diarrhoea—Dactinomycin—skin cancer	0.000214	0.000916	CcSEcCtD
Diltiazem—Vomiting—Bleomycin—skin cancer	0.000213	0.000913	CcSEcCtD
Diltiazem—Rash—Bleomycin—skin cancer	0.000211	0.000905	CcSEcCtD
Diltiazem—Dermatitis—Bleomycin—skin cancer	0.000211	0.000904	CcSEcCtD
Diltiazem—ABCB1—epithelium—skin cancer	0.000211	0.0102	CbGeAlD
Diltiazem—Hypersensitivity—Temozolomide—skin cancer	0.000208	0.000892	CcSEcCtD
Diltiazem—Urticaria—Fluorouracil—skin cancer	0.000207	0.000886	CcSEcCtD
Diltiazem—Syncope—Docetaxel—skin cancer	0.000207	0.000885	CcSEcCtD
Diltiazem—Leukopenia—Docetaxel—skin cancer	0.000206	0.000883	CcSEcCtD
Diltiazem—Body temperature increased—Fluorouracil—skin cancer	0.000206	0.000882	CcSEcCtD
Diltiazem—Palpitations—Docetaxel—skin cancer	0.000204	0.000872	CcSEcCtD
Diltiazem—Asthenia—Temozolomide—skin cancer	0.000203	0.000869	CcSEcCtD
Diltiazem—Loss of consciousness—Docetaxel—skin cancer	0.000203	0.000867	CcSEcCtD
Diltiazem—Cough—Docetaxel—skin cancer	0.000201	0.000861	CcSEcCtD
Diltiazem—Pruritus—Temozolomide—skin cancer	0.0002	0.000857	CcSEcCtD
Diltiazem—Nausea—Bleomycin—skin cancer	0.000199	0.000853	CcSEcCtD
Diltiazem—Vomiting—Dactinomycin—skin cancer	0.000199	0.000851	CcSEcCtD
Diltiazem—Rash—Dactinomycin—skin cancer	0.000197	0.000844	CcSEcCtD
Diltiazem—Arthralgia—Docetaxel—skin cancer	0.000196	0.00084	CcSEcCtD
Diltiazem—Myalgia—Docetaxel—skin cancer	0.000196	0.00084	CcSEcCtD
Diltiazem—Chest pain—Docetaxel—skin cancer	0.000196	0.00084	CcSEcCtD
Diltiazem—Diarrhoea—Temozolomide—skin cancer	0.000194	0.000828	CcSEcCtD
Diltiazem—Hypersensitivity—Fluorouracil—skin cancer	0.000192	0.000822	CcSEcCtD
Diltiazem—Dry mouth—Docetaxel—skin cancer	0.000192	0.000821	CcSEcCtD
Diltiazem—Oedema—Docetaxel—skin cancer	0.000188	0.000805	CcSEcCtD
Diltiazem—Dizziness—Temozolomide—skin cancer	0.000187	0.000801	CcSEcCtD
Diltiazem—Infection—Docetaxel—skin cancer	0.000187	0.0008	CcSEcCtD
Diltiazem—Nausea—Dactinomycin—skin cancer	0.000186	0.000795	CcSEcCtD
Diltiazem—Shock—Docetaxel—skin cancer	0.000185	0.000792	CcSEcCtD
Diltiazem—Nervous system disorder—Docetaxel—skin cancer	0.000185	0.00079	CcSEcCtD
Diltiazem—Pruritus—Fluorouracil—skin cancer	0.000184	0.000789	CcSEcCtD
Diltiazem—Thrombocytopenia—Docetaxel—skin cancer	0.000184	0.000788	CcSEcCtD
Diltiazem—Tachycardia—Docetaxel—skin cancer	0.000184	0.000786	CcSEcCtD
Diltiazem—ABCB1—mammalian vulva—skin cancer	0.000183	0.00886	CbGeAlD
Diltiazem—CYP2D6—head—skin cancer	0.000182	0.00882	CbGeAlD
Diltiazem—Vomiting—Temozolomide—skin cancer	0.00018	0.00077	CcSEcCtD
Diltiazem—Anorexia—Docetaxel—skin cancer	0.000179	0.000768	CcSEcCtD
Diltiazem—Rash—Temozolomide—skin cancer	0.000178	0.000763	CcSEcCtD
Diltiazem—Diarrhoea—Fluorouracil—skin cancer	0.000178	0.000763	CcSEcCtD
Diltiazem—Dermatitis—Temozolomide—skin cancer	0.000178	0.000763	CcSEcCtD
Diltiazem—Headache—Temozolomide—skin cancer	0.000177	0.000759	CcSEcCtD
Diltiazem—Hypotension—Docetaxel—skin cancer	0.000176	0.000752	CcSEcCtD
Diltiazem—Dizziness—Fluorouracil—skin cancer	0.000172	0.000738	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000171	0.000734	CcSEcCtD
Diltiazem—Insomnia—Docetaxel—skin cancer	0.00017	0.000728	CcSEcCtD
Diltiazem—Paraesthesia—Docetaxel—skin cancer	0.000169	0.000723	CcSEcCtD
Diltiazem—Nausea—Temozolomide—skin cancer	0.000168	0.000719	CcSEcCtD
Diltiazem—Dyspnoea—Docetaxel—skin cancer	0.000168	0.000718	CcSEcCtD
Diltiazem—Somnolence—Docetaxel—skin cancer	0.000167	0.000716	CcSEcCtD
Diltiazem—Vomiting—Fluorouracil—skin cancer	0.000166	0.000709	CcSEcCtD
Diltiazem—Dyspepsia—Docetaxel—skin cancer	0.000166	0.000709	CcSEcCtD
Diltiazem—Rash—Fluorouracil—skin cancer	0.000164	0.000703	CcSEcCtD
Diltiazem—Dermatitis—Fluorouracil—skin cancer	0.000164	0.000703	CcSEcCtD
Diltiazem—Decreased appetite—Docetaxel—skin cancer	0.000164	0.0007	CcSEcCtD
Diltiazem—Headache—Fluorouracil—skin cancer	0.000163	0.000699	CcSEcCtD
Diltiazem—ABCB1—lymphoid tissue—skin cancer	0.000163	0.00787	CbGeAlD
Diltiazem—Gastrointestinal disorder—Docetaxel—skin cancer	0.000162	0.000695	CcSEcCtD
Diltiazem—Fatigue—Docetaxel—skin cancer	0.000162	0.000694	CcSEcCtD
Diltiazem—Pain—Docetaxel—skin cancer	0.000161	0.000689	CcSEcCtD
Diltiazem—Constipation—Docetaxel—skin cancer	0.000161	0.000689	CcSEcCtD
Diltiazem—ABCB1—female reproductive system—skin cancer	0.000157	0.00759	CbGeAlD
Diltiazem—Feeling abnormal—Docetaxel—skin cancer	0.000155	0.000664	CcSEcCtD
Diltiazem—Nausea—Fluorouracil—skin cancer	0.000155	0.000663	CcSEcCtD
Diltiazem—Abdominal pain—Docetaxel—skin cancer	0.000149	0.000637	CcSEcCtD
Diltiazem—Body temperature increased—Docetaxel—skin cancer	0.000149	0.000637	CcSEcCtD
Diltiazem—Hypersensitivity—Docetaxel—skin cancer	0.000139	0.000593	CcSEcCtD
Diltiazem—Asthenia—Docetaxel—skin cancer	0.000135	0.000578	CcSEcCtD
Diltiazem—Pruritus—Docetaxel—skin cancer	0.000133	0.00057	CcSEcCtD
Diltiazem—ABCB1—head—skin cancer	0.000131	0.00634	CbGeAlD
Diltiazem—Diarrhoea—Docetaxel—skin cancer	0.000129	0.000551	CcSEcCtD
Diltiazem—Dizziness—Docetaxel—skin cancer	0.000124	0.000532	CcSEcCtD
Diltiazem—Vomiting—Docetaxel—skin cancer	0.00012	0.000512	CcSEcCtD
Diltiazem—Rash—Docetaxel—skin cancer	0.000119	0.000508	CcSEcCtD
Diltiazem—Dermatitis—Docetaxel—skin cancer	0.000119	0.000507	CcSEcCtD
Diltiazem—Headache—Docetaxel—skin cancer	0.000118	0.000504	CcSEcCtD
Diltiazem—Nausea—Docetaxel—skin cancer	0.000112	0.000478	CcSEcCtD
Diltiazem—ABCB1—lymph node—skin cancer	9.18e-05	0.00444	CbGeAlD
